Kim J, Wess J, van Rhee A M, Schöneberg T, Jacobson K A
Molecular Recognition Section, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Biol Chem. 1995 Jun 9;270(23):13987-97. doi: 10.1074/jbc.270.23.13987.
The A2a adenosine receptor is a member of the G-protein coupled receptor family, and its activation stimulates cyclic AMP production. To determine the residues which are involved in ligand binding, several residues in transmembrane domains 5-7 were individually replaced with alanine and other amino acids. The binding properties of the resultant mutant receptors were determined in transfected COS-7 cells. To study the expression levels in COS-7 cells, mutant receptors were tagged at their amino terminus with a hemagglutinin epitope, which allowed their immunological detection in the plasma membrane by the monoclonal antibody 12CA5. The functional properties of mutant receptors were determined by measuring stimulation of adenylate cyclase. Specific binding of [3H]CGS 21680 (15 nM) and [3H]XAC (4 nM), an A2a agonist and antagonist, respectively, was absent in the following Ala mutants: F182A, H250A, N253A, I274A, H278A, and S281A, although they were well expressed in the plasma membrane. The hydroxy group of Ser-277 is required for high affinity binding of agonists, but not antagonists. An N181S mutant lost affinity for adenosine agonists substituted at N6 or C-2, but not at C-5'. The mutant receptors I274A, S277A, and H278A showed full stimulation of adenylate cyclase at high concentrations of CGS 21680. The functional agonist potencies at mutant receptors that lacked radioligand binding were > 30-fold less than those at the wild type receptor. His-250 appears to be a required component of a hydrophobic pocket, and H-bonding to this residue is not essential. On the other hand, replacement of His-278 with other aromatic residues was not tolerated in ligand binding. Thus, some of the residues targeted in this study may be involved in the direct interaction with ligands in the human A2a adenosine receptor. A molecular model based on the structure of rhodopsin, in which the 5'-NH in NECA is hydrogen bonded to Ser-277 and His-278, was developed in order to visualize the environment of the ligand binding site.
A2a 腺苷受体是 G 蛋白偶联受体家族的成员,其激活可刺激环磷酸腺苷(cAMP)的产生。为了确定参与配体结合的残基,跨膜结构域 5 - 7 中的几个残基分别被丙氨酸和其他氨基酸取代。在转染的 COS - 7 细胞中测定所得突变受体的结合特性。为了研究在 COS - 7 细胞中的表达水平,突变受体在其氨基末端用血凝素表位进行标记,这使得它们能够通过单克隆抗体 12CA5 在质膜中进行免疫检测。通过测量腺苷酸环化酶的刺激来确定突变受体的功能特性。在以下 Ala 突变体中,分别作为 A2a 激动剂和拮抗剂的 [3H]CGS 21680(15 nM)和 [3H]XAC(4 nM)的特异性结合缺失:F182A、H250A、N253A、I274A、H278A 和 S281A,尽管它们在质膜中表达良好。Ser - 277 的羟基是激动剂高亲和力结合所必需的,但拮抗剂则不需要。N181S 突变体对在 N6 或 C - 2 位取代的腺苷激动剂失去亲和力,但对 C - 5' 位取代的激动剂则没有。突变受体 I274A、S277A 和 H278A 在高浓度的 CGS 21680 下显示出腺苷酸环化酶的完全刺激。缺乏放射性配体结合的突变受体的功能性激动剂效力比野生型受体低 > 30 倍。His - 250 似乎是疏水口袋的必需组成部分,与该残基形成氢键并非必不可少。另一方面,用其他芳香族残基取代 His - 278 在配体结合中是不能容忍的。因此,本研究中靶向的一些残基可能参与了人 A2a 腺苷受体中与配体的直接相互作用。基于视紫红质结构构建了一个分子模型,其中 NECA 中的 5'-NH 与 Ser - 277 和 His - 278 形成氢键,以便可视化配体结合位点的环境。